Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study

Tamaki Tanaka(Kagawa University), Atsushi Hongo(Okayama University), Kimihiko Ito(Yamagata University), Kazuhiro Takehara(Shikoku Cancer Center), Tomoka Usami, Kotaro Sueoka(Yamaguchi University), Yosuke Konno(Hokkaido University of Science), Shinya Sato(Tokuyama (Japan)), Iemasa Koh(Hiroshima University), Masahiro Kagabu(Iwate Medical University), Hiroko Nakamura(Kure Medical Center), Keiichiro Nakamura, Noriomi Matsumura(Kindai University), Satoe Fujiwara(Osaka University of Pharmaceutical Sciences), Masako Ishikawa(Shimane University), Kei Hirabayashi(Tokuyama (Japan)), Masato Nishimura(Tokushima Prefectural Central Hospital), Eiji Kondo(Mie University), Atsushi Arakawa(Nagoya City University)
Gynecologic Oncology Reports
April 9, 2025
Cited by 1


Related Papers